Alexandre Coté

Follow

Person

Laval, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds for inhibiting NLRP3 and uses thereof
- Patent number 11,319,319
- Issue date May 3, 2022
- Ventus Therapeutics U.S., Inc.
- Stéphane Dorich
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240174668
- Publication date May 30, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240158396
- Publication date May 16, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20230159526
- Publication date May 25, 2023
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20220340567
- Publication date Oct 27, 2022
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY